Can an adult male with Crohn's disease continue intramuscular testosterone therapy during a disease flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Continue Testosterone Injections During a Crohn's Flare?

Yes, you can continue intramuscular testosterone therapy during a Crohn's disease flare-up, and there is no evidence requiring you to stop it. In fact, emerging evidence suggests testosterone may have beneficial immunomodulatory effects in Crohn's disease.

Key Evidence Supporting Continuation

No Contraindication in Guidelines or Drug Labels

The extensive Crohn's disease management guidelines 1, 2, 3, 4, 5 make no mention of testosterone therapy as a contraindication or concern during active disease or flares. The FDA-approved testosterone cypionate label 6 lists no inflammatory bowel disease-related contraindications or warnings.

Potential Beneficial Effects

Recent observational research actually suggests testosterone may improve Crohn's disease activity:

  • In hypogonadal men with Crohn's disease, testosterone replacement significantly improved disease activity. A registry study of 92 men receiving testosterone undecanoate showed the Crohn's Disease Activity Index declined from 239.36 to 71.67 over 84 months, with corresponding decreases in C-reactive protein (12.89 to 1.78 mg/L) and leukocyte counts 7.

  • A pilot study of 13 elderly hypogonadal men with Crohn's disease showed similar improvements in disease activity scores (CDAI from 243 to 89) and inflammatory markers when testosterone was normalized 8.

The proposed mechanism is testosterone's immunosuppressive effects, which may reduce chronic intestinal wall inflammation 7, 8.

Important Caveats About Testosterone and IBD

Gender-Affirming Testosterone May Differ

One recent study found that transgender individuals receiving masculinizing testosterone therapy had higher flare rates (51%) compared to those receiving estrogen (26%) 9. However, this was in the context of gender-affirming hormone therapy at supraphysiologic doses, not testosterone replacement for hypogonadism. Additionally, those with active IBD at hormone initiation were 5 times more likely to flare 9.

Testosterone Deficiency is Common in Active Crohn's

Men with active Crohn's disease often have lower testosterone levels 10, 11. One study found 17.6% of male IBD patients had testosterone <10.4 nmol/L 11. While active disease was associated with lower testosterone in univariate analysis, this relationship wasn't independent in multivariate analysis 11.

Practical Management Approach

During a flare:

  • Continue your scheduled testosterone injections as prescribed 6
  • Focus on treating the Crohn's flare with appropriate IBD therapies (corticosteroids for acute flares, followed by immunomodulators or biologics for maintenance) 1, 2, 3
  • If you're hypogonadal, maintaining normal testosterone levels may actually support better disease control 7, 8

Monitor for:

  • Standard testosterone therapy side effects (polycythemia, prostate issues)
  • Crohn's disease activity through clinical symptoms and biomarkers (C-reactive protein, fecal calprotectin)

Consider checking testosterone levels if you have prolonged active disease, as inflammation may suppress testosterone production 10, 11.

The evidence does not support stopping testosterone during a Crohn's flare, and continuation appears safe with potential benefits for disease control in hypogonadal men.

References

Research

ACG Clinical Guideline: Management of Crohn's Disease in Adults.

The American journal of gastroenterology, 2025

Related Questions

Is hormone replacement therapy (estrogen ± progestin) safe for a woman with ulcerative colitis who is on a biologic therapy?
In a 68-year-old man with Crohn disease on postoperative day 2 after small bowel resection who presents with hematochezia, hypotension, tachycardia, severe anemia, and a poor pulse oximetry waveform, what is the most likely cause of the unreliable pulse oximetry readings?
What antibiotics are safe for an adult patient with Crohn’s disease who has no known drug allergies?
What are the appropriate antibiotics for an adult with Crohn disease who requires treatment for an acute flare, suspected bacterial overgrowth, perianal abscess, or fistula?
What is the first-line treatment for a 13-year-old female with Crohn disease presenting with chronic diarrhea and altered bowel habits for 3–4 months and colonoscopic findings of transmural inflammation?
Among gliclazide, sitagliptin, and metformin, which medication is most likely to cause hypoglycemia?
Does orforglipron (Foundayo) have any drug interaction with quetiapine (Seroquel), metoprolol, and olanzapine (Zyprexa)?
What are the recommended assessment and management strategies for dysphagia in a patient with dementia?
Patient on 10 mg warfarin (Coumadin) was held for 5 days, restarted 3 days ago, and now has an INR of 1.0; how should anticoagulation be managed?
How should severe joint pain in a patient with celiac disease be evaluated and managed?
Can an adult HIV‑positive patient who is virologically suppressed and currently taking Descovy (emtricitabine/tenofovir alafenamide) plus Tivicay (dolutegravir) be switched on the same day to Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.